Landin B, Jeppsson J O
Department of Clinical Chemistry, Malmö General Hospital, University of Lund, Sweden.
Hemoglobin. 1993 Aug;17(4):303-18. doi: 10.3109/03630269308997484.
Here we report the occurrence of five different beta chain hemoglobin variants not previously described in Sweden. The variants were found during quantification of HbA1c using ion exchange high performance liquid chromatography (HPLC) or isoelectrofocusing. Samples were examined either at protein level by separation of globin chains on C8 reversed phase HPLC, digestion with trypsin or lysylendopeptidase and separation of peptides by C18 reversed phase HPLC, or at DNA level by direct nucleotide sequencing of double-stranded DNA fragments amplified from exon 1 + 2 of the beta-globin gene. The variants were: Hb Raleigh [beta 1 (NA1)Val-->Ac-Ala], Hb J-Baltimore [beta 16(A13)Gly-->Asp], Hb Tacoma [beta 30(B12)Arg-->Ser], Hb K-Ibadan [beta 46(CD5)Gly-->Glu], and Hb Fukuyama [beta 77(EF1)His-->Tyr]. Hb Tacoma, Hb K-Ibadan, and Hb Fukuyama were slightly unstable in the isopropanol test, but no signs of hemolysis were found in the patients who all had normal hematological findings.
在此我们报告在瑞典未曾描述过的五种不同的β链血红蛋白变体的出现情况。这些变体是在使用离子交换高效液相色谱法(HPLC)或等电聚焦法定量糖化血红蛋白(HbA1c)的过程中发现的。样本通过以下方式进行检测:在蛋白质水平,通过在C8反相HPLC上分离珠蛋白链、用胰蛋白酶或赖氨酰内肽酶消化以及在C18反相HPLC上分离肽段;或者在DNA水平,通过对从β珠蛋白基因外显子1 + 2扩增的双链DNA片段进行直接核苷酸测序。这些变体分别是:Hb Raleigh [β1(NA1)Val→Ac - Ala]、Hb J - Baltimore [β16(A13)Gly→Asp]、Hb Tacoma [β30(B12)Arg→Ser]、Hb K - Ibadan [β46(CD5)Gly→Glu]和Hb Fukuyama [β77(EF1)His→Tyr]。Hb Tacoma、Hb K - Ibadan和Hb Fukuyama在异丙醇试验中略有不稳定,但在所有血液学检查结果均正常的患者中未发现溶血迹象。